再鼎医药再思考——估值“底部”的动态性

研究进化论
Nov 25, 2025

之前在再鼎医药思考文章里,提到了再鼎医药虽然各种miss,但也还存在一些韧性,20亿美金差不多是相对的估值底部位置,这篇文章重新来聊聊这个估值,特别是在各种潜在可能性的动态调整。从股价下跌过程中的各种负面观点出发,以正面的角度再来理解一下,并不是为了辩论,而是投资中很多事情都是一体两面的,都需要从投资决策角度多元化的去理解:licensein引进模式是悖论。简单一点来说就是,用USD做成本来赚...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10